165 related articles for article (PubMed ID: 27505444)
1. Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda.
Rosen S; Fox MP; Larson BA; Sow PS; Ehrenkranz PD; Venter F; Manabe YC; Kaplan J;
PLoS Med; 2016 Aug; 13(8):e1002106. PubMed ID: 27505444
[TBL] [Abstract][Full Text] [Related]
2. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
Menon S
J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
[TBL] [Abstract][Full Text] [Related]
3. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
[TBL] [Abstract][Full Text] [Related]
4. Strategies to optimize HIV treatment outcomes in resource-limited settings.
Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
[TBL] [Abstract][Full Text] [Related]
5. Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.
Uthman RT; Sutton AJ; Jackson LJ; Uthman OA
PLoS One; 2018; 13(1):e0191465. PubMed ID: 29360841
[TBL] [Abstract][Full Text] [Related]
6. Commentary: Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step.
Laurent C
J Public Health Policy; 2010 Dec; 31(4):401-6. PubMed ID: 21119647
[TBL] [Abstract][Full Text] [Related]
7. Challenges and perspectives of compliance with pediatric antiretroviral therapy in Sub-Saharan Africa.
Dahourou DL; Leroy V
Med Mal Infect; 2017 Dec; 47(8):511-518. PubMed ID: 28943171
[TBL] [Abstract][Full Text] [Related]
8. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy in sub-Saharan Africa.
Müller O; Corrah T; Katabira E; Plummer F; Mabey D
Lancet; 1998 Jan; 351(9095):68. PubMed ID: 9433449
[No Abstract] [Full Text] [Related]
10. The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.
Siedner MJ; Bwana MB; Moosa MS; Paul M; Pillay S; McCluskey S; Aturinda I; Ard K; Muyindike W; Moodley P; Brijkumar J; Rautenberg T; George G; Johnson B; Gandhi RT; Sunpath H; Marconi VC
HIV Clin Trials; 2017 Jul; 18(4):149-155. PubMed ID: 28720039
[TBL] [Abstract][Full Text] [Related]
11. HIV agenda must be prioritised to reduce deaths from AIDS in sub-Saharan Africa.
Cousins S
BMJ; 2017 Jul; 358():j3638. PubMed ID: 28751474
[No Abstract] [Full Text] [Related]
12. Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.
Mikkelsen E; Hontelez JA; Jansen MP; Bärnighausen T; Hauck K; Johansson KA; Meyer-Rath G; Over M; de Vlas SJ; van der Wilt GJ; Tromp N; Bijlmakers L; Baltussen RM
PLoS Med; 2017 Feb; 14(2):e1002240. PubMed ID: 28222126
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
Reid SE; Reid CA; Vermund SH
Int J STD AIDS; 2004 Nov; 15(11):713-6. PubMed ID: 15537453
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa.
Sellier P; Clevenbergh P; Ljubicic L; Simoneau G; Evans J; Delcey V; Diemer M; Bendenoun M; Mouly S; Bergmann JF
Clin Infect Dis; 2006 Sep; 43(5):654-7. PubMed ID: 16886162
[TBL] [Abstract][Full Text] [Related]
15. Towards test and treat strategy for HIV in sub-Saharan Africa.
Nsanzimana S; Kanters S; Mills E
BMJ; 2015 Dec; 351():h6839. PubMed ID: 26714871
[No Abstract] [Full Text] [Related]
16. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
[TBL] [Abstract][Full Text] [Related]
17. Scaling up HIV prevention: why routine or mandatory testing is not feasible for sub-Saharan Africa.
Asante A
Bull World Health Organ; 2007 Aug; 85(8):644-6. PubMed ID: 17768526
[No Abstract] [Full Text] [Related]
18. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.
Sutcliffe CG; van Dijk JH; Bolton C; Persaud D; Moss WJ
Lancet Infect Dis; 2008 Aug; 8(8):477-89. PubMed ID: 18652994
[TBL] [Abstract][Full Text] [Related]
19. Bottlenecks to HIV care and treatment in sub-Saharan Africa: a multi-country qualitative study.
Wringe A; Renju J; Seeley J; Moshabela M; Skovdal M
Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736397
[No Abstract] [Full Text] [Related]
20. Does early ART in sub-Saharan Africa decrease mortality?
Katz IT; Siedner MJ
Lancet HIV; 2015 Sep; 2(9):e354-5. PubMed ID: 26423540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
